Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.

Abstract: An ultrafine powder manufacturing system is described. The system comprises a tube made of ceramic or quartz and a fine nozzle integrally formed in the lower part of the tube, wraps the outside of the tube with an induction heater to melt a metal raw material supplied into the tube and cause it to flow through the nozzle, and supplies a spray gas through orifices arranged to surround the nozzle in a state spaced apart from the nozzle to spray the gas onto the flowing melt to manufacture ultrafine powder.

Abstract: A device and method of estimating state-of-health of a battery is provided. A device of estimating a state-of-health (SOH) of a battery includes: a memory configured to load a program for calculating a state-of-balance (SOB) value by voltage of a plurality of cells constituting the battery and estimating a state-of-health balance value which is a state-of-health value of the battery to which the state-of-balance value by voltage is applied; and a processor configured to execute instructions included in the program loaded by the memory. A device and method of estimating state-of-charge of a battery is provided. A device of estimating state-of-charge (SOC) of a battery includes: a memory configured to load a program for correcting a voltage-to-remaining capacity correlation, in which a battery voltage is matched for each remaining capacity, based on a state-of-balance value by voltage of the battery; and a processor configured to execute instructions included in the program loaded in the memory.

Abstract: A display device includes a driving frequency calculator configured to divide output image data into central, intermediate, and peripheral images respectively corresponding to central, intermediate, and peripheral visual field regions, calculate spatial frequencies of the central image, the intermediate image, and the peripheral image, calculate critical flicker frequencies of the central visual field region, the intermediate visual field region, and the peripheral visual field region based on the spatial frequencies and based on viewing angles of the central visual field region, the intermediate visual field region, and the peripheral visual field region, and determine driving frequencies of the central visual field region, the intermediate visual field region, and the peripheral visual field region based on the critical flicker frequencies, and a display panel configured to display an image based on the output image data and based on the driving frequencies.

Abstract: Embodiments of inventive concepts relate to a neuromorphic circuit including a flash memory-based spike regulator capable of generating a stable spike signal with a small number of devices. The neuromorphic circuit may generate a simple and stable spike signal using a flash memory-based spike regulator. Therefore, it is possible to implement a semiconductor neuromorphic circuit at low power and low cost by using the spike regulator of the present invention. Example embodiments of inventive concepts provide a neuromorphic circuit comprising a control signal generator for generating a control signal for generating a pulse signal; and a spike regulator for generating a spike signal in response to the control signal.

Abstract: The inventive concept provides a substrate treating apparatus.

Abstract: A substrate processing apparatus includes a rotation unit supporting and rotating a substrate, a chemical ejection unit ejecting a chemical fluid toward the rotation unit, a chemical recovery unit disposed close to the rotation unit and collecting a chemical fluid scattered from the rotation unit, a first lifting unit coupled to the chemical recovery unit and moving upward and downward the chemical recovery unit relative to the rotation unit, and a first position correction member allowing the chemical recovery unit to be elastically supported by the first lifting unit and changing a relative position of the chemical recovery unit with respect to the lifting unit.

Abstract: A novel peptide, a polynucleotide encoding the peptide, an expression vector including the polynucleotide, and a pharmaceutical composition, quasi-drug composition, or health functional food composition including the peptide are disclosed. Uses of the peptide, polynucleotide, expression vector, and compositions are also disclosed.

Abstract: Provided are a novel peptide, a polynucleotide encoding the peptide, an expression vector including the polynucleotide, and a pharmaceutical composition including the peptide, a quasi-drug composition including the peptide, and a health functional food composition including the peptide.

Abstract: A gas sampling apparatus having a sampling film in a cartridge includes the cartridge configured to store and send the sampling film out, and the sampling film detachable from the cartridge, wherein the sampling film is configured to adsorb a target material and prevent disturbance between sampled target materials.

Abstract: A drug mixing unit for a syringe is disclosed. The drug mixing unit contains a barrel member having a first flow path through which a liquid drug is to be pushed in; and a plug member having an insertion part inserted into the barrel member, the insertion part having a second flow path, for drawing out a drug mixture, formed on inner side thereof and a through hole, connected to the second flow path, formed on one surface thereof, wherein the plug member is connected to the barrel member to form a predetermined drug mixing space, the drug mixing space has a drug to be mixed with the liquid drug that has been pushed in through the first flow path. The unit also contain a third flow path, through which the drug mixture flows from the drug mixing space to the through hole.

Abstract: The present invention provides a pharmaceutical composition for preventing or treating periodontal disease or a dislocated traumatic tooth, comprising a peptide of a specific amino acid sequence and a composition for regenerating periodontium.

Abstract: An oral care composition for alleviating dentin hyperesthesia is disclosed. The oral care composition includes a peptide consisting of an amino acid sequence of the following Formula 1: K—Y-R1-R2-R3-R4-R5-R6-R7-R8??(Formula 1) wherein R1 is arginine (R), lysine (K) or glutamine (Q); R2 is arginine (R) or glutamine (Q); R3, R4, and R5 are arginine (R) or lysine (K), respectively; R6 is asparagine (N) or serine(S); and R7 and R8 are lysine (K) or tyrosine (Y), respectively.

Abstract: According to an embodiment of the present invention, there are provided an exhaust assembly capable of uniformly forming an air flow in an exhaust step of discharging a gas to the outside, and a liquid processing apparatus and substrate processing equipment including the exhaust assembly. According to the present invention, the exhaust assembly that discharges a gas generated in a substrate processing process includes at least two or more intake ports into which the gas flows, a body portion that communicates with the intake ports and provides symmetrical paths for discharging the gas, a guide portion that is installed to guide a flow of the gas at the body portion, and an exhaust port from which the gas is discharged.

Abstract: A toothpaste composition for alleviating dentin hyperesthesia is disclosed. The composition includes a peptide consisting of an amino acid sequence of the following Formula 1: K-Y-R1-R2-R3-R4-R5-R6-R7-R8??(Formula 1) wherein R1 is arginine (R), lysine (K) or glutamine (Q); R2 is arginine (R) or glutamine (Q); R3, R4, and R5 are arginine (R) or lysine (K), respectively; R6 is asparagine (N) or serine (S); and R7 and R8 are lysine (K) or tyrosine (Y), respectively.

Abstract: The inventive concept provides a substrate treating apparatus.

Abstract: Provided are a novel peptide, a polynucleotide encoding the peptide, an expression vector including the polynucleotide, and a pharmaceutical composition including the peptide, a quasi-drug composition including the peptide, and a health functional food composition including the peptide.

Abstract: A novel peptide and a composition including the peptide are disclosed. The composition may be a pharmaceutical composition, a quasi-drug composition, a dietary supplement, or a food composition. A polynucleotide encoding the peptide and an expression vector including the polynucleotide are also disclosed. The peptide promotes regeneration of hard tissue and is useful for treating dentin-dental pulp diseases or periodontal diseases.

Abstract: Provided are compositions including a CPNE4 protein or a polynucleotide encoding thereof, a pharmaceutical composition, a quasi-drug composition, a dietary supplement, and a health functional food composition. A method for preventing or treating dentin-dental disease or periodontal disease and a method and a method for promoting regeneration of hard tissue including dentin, bone and cementum, and/or pulp tissue are disclosed.

Abstract: A toothpaste composition for alleviating dentin hyperesthesia is disclosed. The composition includes a peptide consisting of an amino acid sequence of the following Formula 1: K-Y-R1-R2-R3-R4-R5-R6-R7-R8??(Formula 1) wherein R1 is arginine (R), lysine (K) or glutamine (Q); R2 is arginine (R) or glutamine (Q); R3, R4, and R5 are arginine (R) or lysine (K), respectively; R6 is asparagine (N) or serine (S); and R7 and R8 are lysine (K) or tyrosine (Y), respectively.